Cardinal Health Inc (CAH) is now in the Overvalued zone, suggesting that its current forward PE ratio of 20.58 is considered Overvalued compared with the five-year average of 13.11. The fair price of Cardinal Health Inc (CAH) is between 137.31 to 185.79 according to relative valuation method. Compared to the current price of 229.88 USD , Cardinal Health Inc By Overvalued By 23.73%.

Relative Value

Fair Zone

137.31-185.79

Current Price：229.88

23.73%

Overvalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Cardinal Health Inc (CAH) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Cardinal Health Inc (CAH) has a current Price-to-Book (P/B) ratio of -17.01. Compared to its 3-year average P/B ratio of -9.68, the current P/B ratio is approximately 75.65% higher. Relative to its 5-year average P/B ratio of -6.58, the current P/B ratio is about 158.55% higher. Cardinal Health Inc (CAH) has a Forward Free Cash Flow (FCF) yield of approximately 9.11%. Compared to its 3-year average FCF yield of 9.55%, the current FCF yield is approximately -4.58% lower. Relative to its 5-year average FCF yield of 10.25%, the current FCF yield is about -11.13% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for CAH competitors is 0.80, providing a benchmark for relative valuation. Cardinal Health Inc Corp (CAH.N) exhibits a P/S ratio of 0.19, which is -76.76% above the industry average. Given its robust revenue growth of 18.75%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of CAH increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of CAH in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is CAH currently overvalued or undervalued?

What is Cardinal Health Inc (CAH) fair value?

CAH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Cardinal Health Inc (CAH) is between 137.31 to 185.79 according to relative valuation method.

How does CAH's valuation metrics compare to the industry average?

The average P/S ratio for CAH's competitors is 0.80, providing a benchmark for relative valuation. Cardinal Health Inc Corp (CAH) exhibits a P/S ratio of 0.19, which is -76.76% above the industry average. Given its robust revenue growth of 18.75%, this premium appears unsustainable.

What is the current P/B ratio for Cardinal Health Inc (CAH) as of Mar 03 2026?

As of Mar 03 2026, Cardinal Health Inc (CAH) has a P/B ratio of -17.01. This indicates that the market values CAH at -17.01 times its book value.

What is the current FCF Yield for Cardinal Health Inc (CAH) as of Mar 03 2026?

As of Mar 03 2026, Cardinal Health Inc (CAH) has a FCF Yield of 9.11%. This means that for every dollar of Cardinal Health Inc's market capitalization, the company generates 9.11 cents in free cash flow.

What is the current Forward P/E ratio for Cardinal Health Inc (CAH) as of Mar 03 2026?

As of Mar 03 2026, Cardinal Health Inc (CAH) has a Forward P/E ratio of 20.58. This means the market is willing to pay $20.58 for every dollar of Cardinal Health Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Cardinal Health Inc (CAH) as of Mar 03 2026?

As of Mar 03 2026, Cardinal Health Inc (CAH) has a Forward P/S ratio of 0.19. This means the market is valuing CAH at $0.19 for every dollar of expected revenue over the next 12 months.

CAH Valuation